176 related articles for article (PubMed ID: 17108046)
1. Incorporation of glycosylphosphatidylinositol-anchored granulocyte- macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles.
Skountzou I; Quan FS; Gangadhara S; Ye L; Vzorov A; Selvaraj P; Jacob J; Compans RW; Kang SM
J Virol; 2007 Feb; 81(3):1083-94. PubMed ID: 17108046
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of GM-CSF or CD40L Enhances the Immunogenicity of Hantaan Virus-Like Particles.
Cheng LF; Wang F; Zhang L; Yu L; Ye W; Liu ZY; Ying QK; Wu XA; Xu ZK; Zhang FL
Front Cell Infect Microbiol; 2016; 6():185. PubMed ID: 28066721
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of CD40 ligand or granulocyte-macrophage colony stimulating factor into Hantaan virus (HTNV) virus-like particles significantly enhances the long-term immunity potency against HTNV infection.
Dong Y; Ma T; Zhang X; Ying Q; Han M; Zhang M; Yang R; Li Y; Wang F; Liu R; Wu X
J Med Microbiol; 2019 Mar; 68(3):480-492. PubMed ID: 30657443
[TBL] [Abstract][Full Text] [Related]
4. Construction and immunological characterization of CD40L or GM-CSF incorporated Hantaan virus like particle.
Ying Q; Ma T; Cheng L; Zhang X; Truax AD; Ma R; Liu Z; Lei Y; Zhang L; Ye W; Zhang F; Xu Z; Shang L; Liu R; Wang F; Wu X
Oncotarget; 2016 Sep; 7(39):63488-63503. PubMed ID: 27542281
[TBL] [Abstract][Full Text] [Related]
5. Th cell-independent immune responses to chimeric hemagglutinin/simian human immunodeficiency virus-like particles vaccine.
Yao Q; Zhang R; Guo L; Li M; Chen C
J Immunol; 2004 Aug; 173(3):1951-8. PubMed ID: 15265929
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in Macaques.
Silva de Castro I; Gordon SN; Liu J; Bissa M; McKinnon K; Trinh HV; Doster MN; Schifanella L; Liyanage NP; Cao J; Cheng O; Foulds K; Roederer M; Koup RA; Shen X; Tomaras GD; Venzon DJ; Forthal DN; Fouts T; Montefiori DC; Tartaglia J; Rao M; Ostrowski M; Franchini G; Vaccari M
J Virol; 2020 Feb; 94(6):. PubMed ID: 31896599
[TBL] [Abstract][Full Text] [Related]
7. Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses.
Patel JM; Kim MC; Vartabedian VF; Lee YN; He S; Song JM; Choi HJ; Yamanaka S; Amaram N; Lukacher A; Montemagno CD; Compans RW; Kang SM; Selvaraj P
Nanomedicine; 2015 Jul; 11(5):1097-107. PubMed ID: 25752855
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles.
Guo L; Lu X; Kang SM; Chen C; Compans RW; Yao Q
Virology; 2003 Sep; 313(2):502-13. PubMed ID: 12954217
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV.
Zhang R; Zhang S; Li M; Chen C; Yao Q
Vaccine; 2010 Jul; 28(31):5114-27. PubMed ID: 20471443
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles.
Yao Q
Res Initiat Treat Action; 2003; 8(2):20-1. PubMed ID: 12845773
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs.
Feng H; Zhang H; Deng J; Wang L; He Y; Wang S; Seyedtabaei R; Wang Q; Liu L; Galipeau J; Compans RW; Wang BZ
Sci Rep; 2015 Jul; 5():11856. PubMed ID: 26150163
[TBL] [Abstract][Full Text] [Related]
12. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
[TBL] [Abstract][Full Text] [Related]
13. Intranasal immunization with SIV virus-like particles (VLPs) elicits systemic and mucosal immunity.
Yao Q; Vuong V; Li M; Compans RW
Vaccine; 2002 Jun; 20(19-20):2537-45. PubMed ID: 12057610
[TBL] [Abstract][Full Text] [Related]
14. Influenza virus-like particles composed of conserved influenza proteins and GPI-anchored CCL28/GM-CSF fusion proteins enhance protective immunity against homologous and heterologous viruses.
Liu J; Ren Z; Wang H; Zhao Y; Wilker PR; Yu Z; Sun W; Wang T; Feng N; Li Y; Wang H; Ji X; Li N; Yang S; He H; Qin C; Gao Y; Xia X
Int Immunopharmacol; 2018 Oct; 63():119-128. PubMed ID: 30081250
[TBL] [Abstract][Full Text] [Related]
15. Chimeric HIV-1 envelope glycoproteins with potent intrinsic granulocyte-macrophage colony-stimulating factor (GM-CSF) activity.
Isik G; van Montfort T; Boot M; Cobos Jiménez V; Kootstra NA; Sanders RW
PLoS One; 2013; 8(4):e60126. PubMed ID: 23565193
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus-like particles activate multiple types of immune cells.
Sailaja G; Skountzou I; Quan FS; Compans RW; Kang SM
Virology; 2007 Jun; 362(2):331-41. PubMed ID: 17276476
[TBL] [Abstract][Full Text] [Related]
17. Murine granulocyte-macrophage colony-stimulating factor expressed from a bicistronic simian immunodeficiency virus-based integrase-defective lentiviral vector does not enhance T-cell responses in mice.
Michelini Z; Negri D; Biava M; Baroncelli S; Spada M; Leone P; Bona R; Blasi M; Nègre D; Klotman ME; Cara A
Viral Immunol; 2014 Dec; 27(10):512-20. PubMed ID: 25343523
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of simian--human immunodeficiency virus-like particles.
Yao Q; Kuhlmann FM; Eller R; Compans RW; Chen C
AIDS Res Hum Retroviruses; 2000 Feb; 16(3):227-36. PubMed ID: 10710211
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of chimeric HIV-SIV-Env and modified HIV-Env proteins into HIV pseudovirions.
Devitt G; Emerson V; Holtkotte D; Pfeiffer T; Pisch T; Bosch V
Virology; 2007 May; 361(2):465-71. PubMed ID: 17208268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
